rdf:type |
|
lifeskim:mentions |
umls-concept:C0009563,
umls-concept:C0015127,
umls-concept:C0021311,
umls-concept:C0087111,
umls-concept:C0524910,
umls-concept:C0678226,
umls-concept:C0699778,
umls-concept:C1280500,
umls-concept:C1314792,
umls-concept:C1707455,
umls-concept:C2348205
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-5
|
pubmed:abstractText |
There is some reluctance to treat intravenous drug users (IVDUs) with chronic hepatitis C (CHC) because of presumed lower compliance and response to antiviral therapy. We intended to evaluate the compliance and response to antiviral treatment for CHC in IVDUs compared with non-IVDUs.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0954-691X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-66
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16394797-Adult,
pubmed-meshheading:16394797-Antiviral Agents,
pubmed-meshheading:16394797-Drug Administration Schedule,
pubmed-meshheading:16394797-Female,
pubmed-meshheading:16394797-Genotype,
pubmed-meshheading:16394797-Hepacivirus,
pubmed-meshheading:16394797-Hepatitis C, Chronic,
pubmed-meshheading:16394797-Humans,
pubmed-meshheading:16394797-Interferon-alpha,
pubmed-meshheading:16394797-Male,
pubmed-meshheading:16394797-Middle Aged,
pubmed-meshheading:16394797-Patient Compliance,
pubmed-meshheading:16394797-Recombinant Proteins,
pubmed-meshheading:16394797-Retrospective Studies,
pubmed-meshheading:16394797-Ribavirin,
pubmed-meshheading:16394797-Substance Abuse, Intravenous,
pubmed-meshheading:16394797-Treatment Outcome,
pubmed-meshheading:16394797-Viral Load
|
pubmed:year |
2006
|
pubmed:articleTitle |
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Ziekenhuis Oost Limburg, Genk, Belgium. geert.robaeys@zol.be
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|